Global Neuropathy Screening Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview

of Global Neuropathy Screening Devices market:
The latest research study on the global Neuropathy Screening Devices market finds that the global Neuropathy Screening Devices market reached a value of USD 80.84 million in 2022. It’s expected that the market will achieve USD 113.31 million by 2028, exhibiting a CAGR of 5.79% during the forecast period.

Neuropathy can develop in many diseases and disorders. Nerve damage may occur in a single location or be widely distributed. It may mainly affect sensory nerves, motor nerves, autonomic nerves or many types of nerves. Any substance that damages nerves will interfere with its ability to transmit accurate signals, resulting in many signs and symptoms.
Neuropathy Screening Devices mainly screen patients for vibration, temperature and pressure sensitivity. It also includes some imaging examination equipment and electromyography equipment, etc.

Short-term Impact
The new coronavirus has been considered a "pandemic" by the World Organization, and few countries can escape its effects. At present, the world's major consumer and production countries, such as the United States, Germany, the United Kingdom, and so on, are all trapped in the mire. Although isolation measures were not taken immediately in order not to affect economic development, the growing severity of the epidemic has affected the normal production of enterprises, as well as consumption, imports and exports between countries. The main consumption areas of Neuropathy Screening Devices are some countries in Europe and US, which are also the hardest hit areas of the current epidemic. It is expected that the sales volume of Neuropathy Screening Devices will not grow too much.
Most agents selling neuropathy screening equipment have changed their business hours or services. With the epidemic becoming more and more serious, some areas have adopted the strategy of city closure, and people's travel has decreased, resulting in a decline in offline passenger flow. Advantages of online sales model are highlighted. The offline retail of Nervous Screening Devices Industry equipment encountered challenges during the outbreak of Covid-19.
Because most enterprises in the market are located in the United States, Europe and other areas affected by the epidemic. With the change of office mode, home office has become the mainstream. In the supply, distribution, manufacturing and quality links, improve the safety and hygiene standards and strict protection standards to ensure the quality and safety of products. The epidemic situation promoted the improvement of safety standards of Neuropathy Screening Devices.

Region Overview:
From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:
Owen Mumford is one of the major players operating in the Neuropathy Screening Devices market, holding a share of 23.11% in 2021.

Owen Mumford is a global leader in medical device design and manufacture, leading innovation in this space and delivering medical device solutions that respond to customer and market needs. For almost 70 years Owen Mumford have collaborated with pharmaceutical, biotechnology and diagnostic companies, medical distributors, healthcare professionals and patients. Through this well-established network Owen Mumford deliver the highest levels of safety, comfort and accuracy in the treatment and diagnosis of chronic diseases such as rheumatoid arthritis, diabetes and multiple sclerosis.

Impeto Medical SAS is a privately owned medical device company formed in June 2005. Its corporate headquarters are located in Paris, France. Two subsidiaries have been created: Beijing Impeto Medical in China and Impeto Medical Inc. in San Diego, U.S. Provide screening tests for the medical community to deal with epidemic metabolic diseases and their complications.

Segmentation Overview:
Among different product types, Sensory segment is anticipated to contribute the largest market share in 2028.

Application Overview:
By application, the Hospitals segment occupied the biggest share from 2018 to 2022.

The report covers a research time span from 2018 to 2029; combines extensive quantitative analysis and exhaustive qualitative analysis; presents not only an overview of the global Neuropathy Screening Devices market in metrics of sales, revenue, growth rate, but also a deeper dive into the segmented market by region, product type and downstream industry, showing the readers a clear and distinct picture of how the market is distributed from different perspectives.

For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.

As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.

Research Scope
This report provides an overview of the global Neuropathy Screening Devices market and analyzes the segmented market by product type, downstream industry, and region, presenting data points such as sales, revenue, growth rate, explaining the current status and future trends of the Neuropathy Screening Devices and its sub-markets in an intuitive way.

Key Companies in the global Neuropathy Screening Devices market covered in Chapter 3:
Impeto Medical
Mediracer Ltd
Phi Med Europe
Prosenex
Owen Mumford
Beijing Oerhuatai Technology
Trigocare International Gmbh
Medical Monofilament Manufacturing, llc
NeuroMetrix

In Chapter 4 and Chapter 14.2, on the basis of types, the Neuropathy Screening Devices market from 2018 to 2029 is primarily split into:
Thermal
Sensory
Sudomotor
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Neuropathy Screening Devices market from 2018 to 2029 covers:
Hospitals
Clinics
Diagnostic Centers
Drug Stores

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:
North America (United States, Canada)

Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)

Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)

Latin America (Brazil, Mexico, Argentina)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)

Key Factors Considered

COVID-19
Amid the COVID-19 crisis, the Neuropathy Screening Devices market has definitely taken a hit. The report describes the market scenario during and post the pandemic in the vision of upstream raw materials, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.

Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it’s going to evolve in the years to come.

Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.

Chapter Outline

Chapter 1 starts the report with a brief overview of the research scope, as well as the definitions of the target market and the subdivisions.

Chapter 2 integrates and sketches the research findings and conclusions in a clear and explicit way.

Chapter 3 presents the competitive landscape by displaying the sales, revenue, and market shares of the top players. It also profiles the major market participants with their business introductions, sales, price, revenue, gross, growth rates, etc.

Chapter 4 breaks down the market by different product types and shares data correspondingly with the aim of helping the readers know how the market is distributed by type.

Chapter 5 segments the market by downstream industry, with data covers sales, revenue, and growth rate tracing back to 2018.

Chapter 6 is the analysis of the whole market industrial chain, ranging from upstream raw materials to downstream customers, with regional conflicts taken into consideration.

Chapter 7 elaborates on market dynamics. Factors that drive, challenge, or restrain the market are all listed, together with industry news, opportunities, impacts of COVID-19, and SWOT analysis.

Chapter 8 shows the breakdown data at the regional level, which enables the readers to picture the regional competitive pattern of the market and learn about the revenue, sales, and market share of all the major regions.

Chapter 9-13 focus on each and every of the major region, specifically, North America, Europe, Asia Pacific, Latin America, Middle East & Africa. Sales, price, revenue, gross, gross margin, among others, will be all be presented.

Chapter 14 forecasts the future trend of the market not only as a whole but also from the perspective of all segments.

Years considered for this report:

Historical Years:

2018-2022

Base Year:

2022

Estimated Year:

2023

Forecast Period:

2023-2029

Frequently Asked Questions